Regulatory Consulting

Optimizing time to market

Regulatory requirement considerations are a critical part of each clinical research program from beginning to end.

CRS provides regulatory consulting supported by our long-term partner in regulatory affairs. With the knowledge and experience gained through years of working with this partner we offer our clients collaborated support tailored to deal with European and US regulatory requirements, thus optimizing time to market.


REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim

LET’S TALK SCIENCE
Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management

LET’S TALK BUSINESS

BACK TO OVERVIEW

CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.